0001179110-19-006151.txt : 20190516
0001179110-19-006151.hdr.sgml : 20190516
20190516161314
ACCESSION NUMBER: 0001179110-19-006151
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190515
FILED AS OF DATE: 20190516
DATE AS OF CHANGE: 20190516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kollender Richard S
CENTRAL INDEX KEY: 0001415666
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37569
FILM NUMBER: 19832376
MAIL ADDRESS:
STREET 1: C/O QUAKER BIOVENTURES, CIRA CENTRE
STREET 2: 2929 ARCH STREET, 3RD FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104-2868
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Strongbridge Biopharma plc
CENTRAL INDEX KEY: 0001634432
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981130690
STATE OF INCORPORATION: L2
BUSINESS ADDRESS:
STREET 1: 900 NORTHBROOK DRIVE, SUITE 200
CITY: TREVOSE
STATE: PA
ZIP: 19053
BUSINESS PHONE: (610) 254-9200
MAIL ADDRESS:
STREET 1: 900 NORTHBROOK DRIVE, SUITE 200
CITY: TREVOSE
STATE: PA
ZIP: 19053
FORMER COMPANY:
FORMER CONFORMED NAME: Cortendo AB
DATE OF NAME CHANGE: 20150219
4
1
edgar.xml
FORM 4 -
X0306
4
2019-05-15
0
0001634432
Strongbridge Biopharma plc
SBBP
0001415666
Kollender Richard S
900 NORTHBROOK DRIVE
SUITE 200
TREVOSE
PA
19053
1
0
0
0
Ordinary Shares
2019-05-15
4
A
0
40000
0
A
40000
D
Represents a grant of restricted stock units, which vest in full on May 15, 2020, provided that the Reporting Person continues to serve as a member of the board of directors of the Issuer through that date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
/s/ Judith Goldberg, as attorney-in-fact
2019-05-16